Ionis Pharmaceuticals (NASDAQ:IONS) CEO Sells 14,565 Shares of Stock
MarketBeat
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) CEO Brett Monia sold 14,565 shares of the firm's stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $78.41, for a total transaction of $1,142,041.65. Following the transaction, the chief executive officer directly owned 245,571 shares of the company's stock, valued at $19,255,222.11. The trade was a 5.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ:IONS